Role of synthesis repertory in cases of type 2 diabetes mellitus

Application of prescribed medicine from rubrics of Synthesis Repertory in cases of type 2 diabetes mellitus assessed by HbA1c with adjuvant therapy in age group of 30to 60 years a Randomised single blind placebo controlled study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097574

Enrollment

Registered

2025-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Individualized Homeopathic Medicine: Potency Various such as Decimal Centesimal 50Millesimal etc Doses as per need of cases Medicines will be dispensed as per the potency Frequency as p

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient of type 2 diabetes mellitus having HbA1c level 6.5% to 9%. 2.Patients who are taking oral antihyperglycemic medication.

Exclusion criteria

Exclusion criteria: 1.Type 2 diabetes mellitus with complication macrovascular and microvascular.. 2.Pregnant women and lactating women.

Design outcomes

Primary

Measure	Time frame
Type 2 Diabetes Mellitus assessment by using HBA1c Report.Timepoint: HbA1c reports will be assessed from baseline, 3 months, 6 months,9 months, and at the end of treatment.	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactDr Kinnari Ptael

Smt A J SAVLA HOMEOPATHIC COLLEGE MEHSANA

shckalol@gmail.com9428000782

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026